3586 results

PCR Tricuspid Focus Group

21 Apr 2021

Discover an overview of the new initiative’s mission and five ongoing working groups

MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

01 Sep 2024

Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

Author

Yohei Ohno

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Author

Elad Asher

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Author

Nicola Ryan

OPTIMIZE IDE: A randomized trial of a novel, ultra low profile fixed-wire DES

26 Oct 2020

At TCT Connect 2020, Late-Breaking Trial Session IV, the primary results of the OPTIMIZE IDE were presented by Dean J. Kereiakes. Daniele Giacoppo provides a summary of the trial.

Author

Daniele Giacoppo

ISAR REACT 5 - Ticagrelor versus prasugrel in patients with acute coronary syndrome

03 Sep 2019

At the ESC Congress 2019 in Paris, Stefanie Schuepke presented the results of the ISAR REACT 5 study. Read this analysis by Francesco Costa and view a short interview with Stefanie Schuepke.

Author

Francesco Costa